search
Documents
Separation of Teriflunomide and its Organic Impurities per the Proposed USP Monograph in PF 48 (5)
In this technical note, we report the separation of Teriflunomide and its related organic impurities using a Kinetex™ 2.6 µm C18 column compared to a Ascentis® Express 2.7 µm C18 column originally used in the proposed monograph.
Separation of Teriflunomide and its Organic Impurities per the Proposed USP Monograph in PF 48 (5)
In this technical note, we report the separation of Teriflunomide and its related organic impurities using a Kinetex™ 2.6 µm C18 column compared to a Ascentis® Express 2.7 µm C18 column originally used in the proposed monograph.
Document Type:
Technical Notes
Target Industries:
Techniques:
Brands:
Separation Modes:
Reversed Phase
Phases:
Separation of Teriflunomide and its Organic Impurities per the Proposed USP Monograph in PF 48 (5)
In this technical note, we report the separation of Teriflunomide and its related organic impurities using a Kinetex™ 2.6 µm C18 column compared to a Ascentis® Express 2.7 µm C18 column originally used in the proposed monograph.
| Target Industries: | Pharmaceutical |
| Techniques: | HPLC, HPLC Reversed Phase |
| Brands: | Kinetex |
| Separation Modes: | Reversed Phase |
| Phases: | Kinetex C18 |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide